Profile data is unavailable for this security.
About the company
KPC Pharmaceuticals, Inc. is a China-based company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. The Company's main products include natural herbal medicines, traditional Chinese medicines and chemical synthetic drugs, such as central nervous system drugs, cardiovascular and cerebrovascular drugs, anti-parasitic drugs, anti-microbial drugs, anti-gout drugs, hormones and endocrine drugs, hemorrhoids medicines and anti-inflammatory drugs, among others. The Company is also engaged in the production of health products and provision of medical services.
- Revenue in CNY (TTM)7.55bn
- Net income in CNY446.07m
- Incorporated1995
- Employees5.05k
- LocationKPC Pharmaceuticals IncNo. 166Keyi Road, High-tech Development ZoneKUNMING 650106ChinaCHN
- Phone+86 87 168324311
- Fax+86 87 168324267
- Websitehttp://www.kpc.com.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Sinopep Allsin Bphrmctcl Co Ltd | 1.58bn | 421.47m | 10.90bn | 1.55k | 26.32 | 4.17 | -- | 6.92 | 1.88 | 1.88 | 7.14 | 11.91 | 0.4286 | 1.19 | 3.67 | 1,020,281.00 | 11.58 | 5.86 | 16.99 | 7.59 | 67.12 | 55.41 | 27.01 | 17.20 | 0.912 | 24.02 | 0.3477 | 27.59 | 58.69 | 32.24 | 26.20 | 29.99 | 27.32 | -- |
| Heilongjiang ZBD Pharmaceutical Co Ltd | 2.58bn | 114.60m | 10.94bn | 2.55k | 97.34 | 1.41 | -- | 4.24 | 0.1194 | 0.1194 | 2.74 | 8.24 | 0.2118 | 1.48 | 0.7645 | 1,014,704.00 | 0.8822 | 3.48 | 1.17 | 4.78 | 34.52 | 38.93 | 4.17 | 10.08 | 2.23 | -- | 0.2888 | 27.18 | -25.50 | 2.45 | 155.00 | 0.4417 | -25.68 | 4.05 |
| Chongqing Genrix Biophrmctcl Co Ltd | 13.56m | -779.42m | 11.03bn | 547.00 | -- | 4.69 | -- | 813.12 | -2.13 | -2.13 | 0.037 | 6.42 | 0.0039 | 0.1009 | 1.37 | 24,790.27 | -22.22 | -- | -23.06 | -- | 55.87 | -- | -5,747.82 | -- | 18.62 | -- | 0.2454 | -- | 154.92 | -- | -39.03 | -- | -- | -- |
| Mayinglong Pharmaceutical Group Co Ltd | 3.48bn | 482.37m | 11.04bn | 2.88k | 22.89 | 2.76 | -- | 3.17 | 1.12 | 1.12 | 8.08 | 9.28 | 0.6872 | 6.42 | 8.53 | 1,208,299.00 | 9.74 | 10.82 | 11.64 | 13.47 | 44.84 | 41.18 | 14.17 | 14.08 | 4.40 | -- | 0.0936 | 33.04 | -11.20 | 7.38 | -7.46 | 20.26 | 58.33 | 21.67 |
| Liaoning Chengda Biotechnology Co Ltd | 1.72bn | 332.10m | 11.34bn | 1.73k | 33.90 | 1.19 | -- | 6.60 | 0.8032 | 0.8032 | 4.16 | 22.93 | 0.1702 | 0.763 | 1.43 | 991,973.80 | 3.29 | 10.63 | 3.41 | 11.01 | 80.53 | 85.74 | 19.33 | 39.56 | 17.44 | -- | 0.0018 | 31.53 | -3.58 | 4.71 | -34.75 | -5.56 | 39.78 | -- |
| Jiangxi Tianxin Pharmaceutical Co Ltd | 2.01bn | 557.43m | 11.45bn | 2.47k | 20.55 | 2.57 | -- | 5.70 | 1.27 | 1.27 | 4.58 | 10.18 | 0.3977 | 2.75 | 10.26 | 812,720.60 | 11.04 | -- | 11.82 | -- | 41.64 | -- | 27.76 | -- | 6.39 | -- | 0.0234 | -- | -18.34 | -- | -23.51 | -- | -- | -- |
| KPC Pharmaceuticals Inc | 7.55bn | 446.07m | 11.53bn | 5.05k | 25.71 | 2.08 | -- | 1.53 | 0.5924 | 0.5924 | 10.03 | 7.31 | 0.7819 | 2.75 | 2.56 | 1,494,697.00 | 4.64 | 5.42 | 7.75 | 9.13 | 40.84 | 43.68 | 5.94 | 5.70 | 1.51 | -- | 0.172 | 35.75 | -6.99 | 1.64 | 16.05 | 5.79 | -21.33 | 14.87 |
| Henan Lingrui Pharmaceutical Co., Ltd. | 3.56bn | 675.80m | 12.16bn | 2.53k | 17.86 | 4.20 | -- | 3.41 | 1.20 | 1.20 | 6.34 | 5.10 | 0.7489 | 2.24 | 10.18 | 1,408,620.00 | 14.20 | 10.68 | 23.52 | 16.56 | 72.35 | 74.42 | 18.96 | 14.92 | 0.9579 | -- | 0.0073 | 72.80 | 10.31 | 10.03 | 22.09 | 18.49 | -16.47 | 39.77 |
Data as of Nov 05 2024. Currency figures normalised to KPC Pharmaceuticals Inc's reporting currency: Chinese Yuan Renminbi CNY
19.98%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 72.91m | 9.63% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 24.68m | 3.26% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 12.66m | 1.67% |
| China Investment Corp. (Investment Management)as of 30 Sep 2023 | 11.81m | 1.56% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 11.30m | 1.49% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2024 | 7.19m | 0.95% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 3.70m | 0.49% |
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2024 | 2.38m | 0.32% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 2.33m | 0.31% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2024 | 2.25m | 0.30% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
